Malaria vaccine - RMF Dictagene
Latest Information Update: 01 Feb 2005
At a glance
- Originator RMF Dictagene
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 31 Dec 2004 Discontinued - Phase-I for Malaria in Switzerland (unspecified route)
- 22 Mar 2004 Phase-I clinical trials in Malaria in Switzerland (unspecified route)